$PROF Balance Sheet | Understand Stock

$PROF

$5.65 +$0.09 (1.71%) Close

$PROF Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q4 FY2019 As of Dec 31, 2019
Cash
Trade and other receivables (note 4)
Investment tax credits receivable
Inventory (note 5)
Prepaid expenses and deposits
Total current assets
Trade and other receivables
Property and equipment (note 6)
Intangible assets (note 7)
Right-of-use assets (note 8)
Goodwill
Total assets
Accounts payable and accrued liabilities
Deferred revenue
Long-term debt (note 9)
Provisions
Other liabilities (note 9)
Derivative financial instrument (note 9)
Lease liabilities (note 10)
Income taxes payable
Total current liabilities
Deferred tax liability (note 16)
Total liabilities
Share capital (note 11)
Contributed surplus
Accumulated other comprehensive income
Deficit
Total Shareholders' Equity
Assets
Current assets:
Cash
Trade and other receivables, net (note 3)
Inventory (note 4)
Prepaid expenses and deposits
Total current assets
Trade and other receivables, net (note 3)
Property and equipment, net (note 5)
Intangible assets, net (note 6)
Right-of-use assets, net (note 9)
Deferred tax assets, net
Total assets
Liabilities
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities (note 7)
Deferred revenue
Long-term debt (note 8)
Lease liabilities (note 9)
Income tax payable
Total current liabilities
Deferred tax liabilities, net (note 13)
Deferred revenue
Long-term debt (note 8)
Lease liabilities (note 9)
Other non-current liabilities
Total liabilities
Shareholders' equity
Common shares, no par value, unlimited shares authorized, 36,532,594 and 36,293,640 issued and outstanding at June 30, 2026 and December 31, 2025, respectively (note 10)
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Total shareholders' equity
Total liabilities and shareholders' equity

Comments